Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DMRTB1 is a nuclear transcription factor that contains a conserved DM domain and belongs to the DMRT family. It plays a critical role in regulating the transition from mitotic spermatogonia to meiotic spermatocytes, marking a subset of germ cells in developing testes. Changes in its dosage or expression, such as those caused by genetic microdeletion, are strongly associated with impaired spermatogenesis and can lead to male infertility. DMRTB1’s expression is highly tissue-specific—primarily in testis—and its normal function is essential for male germ cell differentiation. Comparative genomics suggests that changes in DMRTB1 contribute to testis size evolution across tetrapods. Although principally involved in reproductive tissue development, recent genetic studies indicate potential additional systemic roles, including influence over gut microbial populations.
Null (no drugs targeting DMRTB1 known)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Doublesex- and mab-3-related transcription factor B1 (DMRTB1).